Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science

---
Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science
Vote:
0 0
Previous Illuccix® Approved in the United Kingdom
Next Japan's Leading Crypto Tax Service, cryptact, Now Available in Canada - Trusted Reports from US$22.50

Related News

Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease

BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs Fund, Gobi and TIMC to Realise Precision and Personalised Gut Microbiome Management for Wellness

Nevisense for skin barrier evaluation included in large Australian birth cohort study

Metabolon Launches Bile Acids and Short Chain Fatty Acids Targeted Panels to Advance Understanding of Microbiome and Gut Metabolome in Health and Disease

Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen

A random placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

menu
menu